PCSA
Processa Pharmaceuticals, Inc. Common
stockNASDAQ
At CloseOct 22, 2026
1.86USD+5.682%(+0.10)16,145
PCSA Financials
In Q2 FY 2026 (ended ), Processa Pharmaceuticals, Inc. Common (PCSA) reported net income of −$3.27M, operating cash flow of −$2M, and assets of $2.07M.
Loading financial flows…